Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ATG9B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | ARHGEF11 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
mRNA | ITGA9 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | MASTL | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | IL1RAP | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | RFTN1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | MIPEP | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | CNPY1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | PEAK1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
mRNA | CFP | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |